Trials / Conditions / Advanced Colorectal Adenocarcinoma
Advanced Colorectal Adenocarcinoma
5 registered clinical trials studyying Advanced Colorectal Adenocarcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Engage Psychosocial Intervention for Cancer Symptoms NCT06555588 | Duke University | N/A |
| Not Yet Recruiting | An Open-label, Multicenter, Single-arm Clinical Study on the Use of Doxorubicin Liposome in Combination With C NCT06753721 | Nanfang Hospital, Southern Medical University | Phase 1 / Phase 2 |
| Withdrawn | Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Met NCT06575725 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic NCT05672316 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Recruiting | A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer NCT05200442 | University of Chicago | Phase 1 / Phase 2 |